Company: EHC
Filing Date: 2025-04-01
Form Type: DEF 14A
Source: 0000785161-25-000013
Chunk: 83

Company: Encompass Health Corp
Filing Date: 2025-04-01
Form: DEF 14A
Chunk 83
---
3, and 2024, respectively, each of which vest in three equal annual installments beginning on the first anniversary of the grant date. The fifth amounts for Messrs. Coltharp and Darby represent supplemental retention grants in February 2023 that fully vest on the third anniversary of the grant date.

<div align='center'>62</div>

(5) The market value reported was calculated by multiplying the closing price of our common stock on the last trading day of 2024, $92.35, by the number of shares set forth in the preceding column.

(6) The PSU awards shown in this column are contingent upon the level of attainment of performance goals for the performance period beginning January 1 of the year in which the grant is made. The determination of the final number of shares earned under each PSU award will be made following the close of a three-year period. The first amount for each officer in this column represents the number of shares calculated based on performance over the 2023-2024 performance period as officially determined by the board of directors in February 2025, which share count shall be subject to a three-year total shareholder return multiplier as of December 31, 2025. The second amount for each officer in this column represents the number of shares to be earned assuming achievement of maximum performance during the 2024-2026 performance period on the normalized earnings per share and return on invested capital objectives. The actual number of restricted shares earned at the end of that performance period may be lower.

(7) The market value reported was calculated by multiplying the closing price of our common stock on the last trading day of 2024, $92.35, by the number of shares set forth in the preceding column.

#### Options Exercised and Stock Vested in 2024
The following table sets forth information concerning the exercise of options and the vesting of shares for our named executive officers in 2024.

|                                      |     |   Option Awards |     |                |     |                          Stock Awards |     |                           |           |
| Name                                 |     |       Number of 
 Shares Acquired 
     on Exercise |     | Value Realized 
    on Exercise 
            ($) |     | Number of  Shares Acquired on Vesting |     | Value Realized on Vesting 
 ($)                       |           |
| Mark J. Tarr                         |     |          44,976 |     |      2,306,414 |     |                                78,723 |